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History
Few would recall the operation pro-
posed by Krasnov in the late 1950s,
sinusotomy [16, 17, 18, 19], which 
is in fact the first seed of non-pene-
trating surgery. Believing that the
maximum resistance to outflow 
resides at the level of sclera in glau-
coma patients, Krasnov proposed 
excising the bulk of sclera overlying
Schlemm’s canal (SC). The obvious
difficulty of the surgical technique,
together with the lack of modern mi-
croscopes at that time, hindered the
popularization of his operation. Also,
in what would later be a stigma of
non-penetrating surgery, he abstractly
reported his success rates without
fully explaining his success criteria
or offering solid arguments on how
his technique functioned.
Many years later Zimmerman 
[31, 32], benefiting from an im-
proved understanding of outflow
mechanisms, proposed what he
termed ab-externo trabeculectomy.
The procedure differs from sinusoto-
my in that Zimmermann advocated
the removal of the inner wall of SC
and the juxtacanalicular trabecular
meshwork (JCT), as well as the 
creation of a superficial scleral flap
guarding the sinusotomy, in the same
manner as in trabeculectomy.
Kozlov [14, 15] suggested ex-
tending the dissection anteriorly to
excise a portion of corneal stroma
together with the deep sclera, expos-
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ing Descemet’s membrane, with the
aim of at creating percolation through
the membrane as well. Stegmann
[29], on the other hand, augmented
the operation by injecting viscoelas-
tic material in the two cut ends of
SC, thus dilating it, and termed the
procedure viscocanalostomy.
Thus the saga of non-penetrating
surgery was forged by visionaries
suggesting ideas, but not offering 
evidence-based medicine to substan-
tiate their concepts. It is a fact that
we are currently overwhelmed by
studies reporting on the results of
one technique or another, often with
conflicting results, in a virtual vacu-
um of studies examining mecha-
nisms of function.
The common concept
The principal common concept of
non-penetration is to create filtration
through a naturally occurring mem-
brane that acts as an outflow resis-
tance site [23], allowing a progres-
sive decrease in intraocular pressure
(IOP) and avoiding postoperative 
ocular hypotony. This membrane, the
trabeculo-Descemet’s membrane
(TDM), consists of the trabecular
meshwork and the peripheral 
Descemet’s membrane. To expose
the membrane a deep sclerokera-
tectomy should be performed, there-
by also providing a postoperative
scleral space. This space may act as
an aqueous reservoir and as a filtra-
tion site that may reduce the need for
a large subconjunctival filtration
bleb thus reducing the risk of late
bleb-related complications.
Mechanisms of function
There are several points of interest
when studying the mechanisms of
function of non-penetrating surger-
ies. Namely, the removal of the inner
wall of SC together with adjacent
trabecular tissue, the aqueous humor
flow through the TDM, the aqueous
resorption after its passage through
the TDM, and the SC dilatation by
viscoelastic injection.
Flow through the TDM
Grant [8], more than 40 years ago,
demonstrated that maximum outflow
resistance resides within the inner
wall of SC together with the JCT.
Various studies have attempted to
identify the nature of the “plug” in
the trabecular meshwork, but to no
avail.
The JCT contains a mixture of
cells, extracellular matrix, and 
aqueous pathways that appear as
empty spaces under electron micros-
copy. The JCT extracellular matrix 
is a combination of glycosamino-
glycan and proteoglycan. With its
morphological structure containing
relatively small openings and tortu-
ous pathways, many studies [7, 8]
have hypothesized that the JCT is
the principal site of outflow resis-
tance.
Passing through the JCT, aqueous
is confronted with an anatomic barri-
er, namely the endothelial lining of
SC. In its normal physiologic state
SC is large enough not to generate
significant outflow resistance. As
IOP increases, the trabecular mesh-
work expands into the SC lumen
[10], causing a concomitant signifi-
cant narrowing.
In non-penetrating glaucoma sur-
gery (NPGS) the canal is unroofed.
As numerous collagenous septa be-
tween the inner and outer walls exist,
it has been demonstrated [27] that
the act of unroofing results in dam-
age to the inner wall as the septa pull
on it. Such damage allows aqueous
access to the canal.
Furthermore, in NPGS the inner
wall of the canal is peeled (ab-exter-
no trabeculectomy). Analysis of the
peeled membrane provided conclu-
sive evidence [9] that includes aside
from the inner wall of SC, the JCT,
and to a lesser extent the corneo-
scleral trabecular meshwork. In that
respect the procedure attempts to re-
move the external portion of the tra-
becular meshwork responsible for
the main aqueous outflow resistance
in a glaucomatous eye.
The TDM offers resistance to
aqueous humor outflow that allows
for a slow decrease in IOP during
surgery and will account for the 
reliable and reproducible IOP on 
the first postoperative day [23].
Thus the main advantage of the
TDM is to reduce the immediate
postoperative complications such as
hypotony, flat anterior chamber,
choroidal detachments and induced
cataract [3].
In an experimental model [30], the
gradual decrease in IOP was studied
and the resistance of the TDM calcu-
lated. Experiments were performed
on enucleated human eyes unsuitable
for keratoplasty. The mean IOP de-
crease speed was 2.7±0.6 mm
Hg/min. The ocular aqueous outflow
resistance dropped from a mean of
5.34±0.19 ml/min/mmHg preopera-
tively to a mean of 0.41±0.16 ml/
min/mmHg postoperatively. The
same study [30] also reported that 
the outflow facility increased from
0.19±0.03 to 24.5±12.6 µl/min/mmHg
after deep sclerectomy.
The TDM resistance thus appears
low enough to ensure a low IOP and
yet sufficient to maintain the anterior
chamber depth and avoid the postop-
erative complications in relation to
hypotony.
The same study histologically
[30] examined the surgical site using
700
ocular perfusion with ferritin, dem-
onstrating that the main outflow
through the TDM occurred at the
level of the trabecular meshwork,
rather than Descemet’s membrane.
This is in line with studies [28] re-
porting on the very limited perme-
ability of Descemet’s membrane,
which by itself is not enough to re-
lieve the elevated pressure in glauco-
ma. In fact, most proponents of
NPGS advocate [25] the creation of
the Descemet’s portion of the TDM
only as a window that can be punc-
tured by Nd:YAG goniopuncture in
cases of elevated postoperative intra-
ocular pressure.
Aqueous resorption
After aqueous humor passage
through the TDM, multiple mecha-
nisms of aqueous resorption have
been proposed: a subconjunctival
bleb, an intrascleral bleb (intrascleral
lake), suprachoroidal filtration, and
an episcleral vein outflow via SC.
As after trabeculectomy, almost
all patients undergoing NPGS have a
diffuse, conjunctival bleb on the first
postoperative day [12]. As demon-
strated by ultrasound biomicroscopy
(UBM) studies, successful cases
show a low-profile and diffuse sub-
conjunctival bleb even years after
surgery [13, 21]. However, this bleb
tends to be shallower and more dif-
fuse than the one seen after trabecul-
ectomy.
Although this has not been stud-
ied, subconjunctival blebs probably
occur more commonly with deep
sclerectomy than with viscocanalos-
tomy. The reason for this is that in
viscocanalostomy [29] the superfici-
al scleral flap is tightly sutured, so as
to force percolating aqueous into the
two surgically created ostia of SC,
while in deep sclerectomy, the flap is
only loosely sutured [26] and a dif-
fuse shallow bleb is desired.
In NPGS, a certain volume of
sclera is removed, ranging between 5
and 8 mm3. Provided the superficial
scleral flap does not collapse, this
scleral volume may be considered as
an intrascleral bleb. The value of in-
trascleral bleb was ascertained by
Roters and co-workers [24], who
showed that absence of intrascleral
bleb in postoperative UBM examina-
tions correlates with lack of IOP
control in viscocanalostomy.
The importance of intrascleral
bleb has prompted research into
ways to keep it patent. The idea of
using a collagen implant was pro-
posed by Kozlov [14, 15]. The con-
cept is simply to occupy this space
during the period of maximal healing
response. After the scarring process
falters, the implant is slowly re-
sorbed 6–9 months postoperatively
[2], leaving behind an aqueous lake.
The intrascleral bleb was ob-
served [13] in more than 90% of pa-
tients who received a collagen im-
plant and the mean volume of the in-
trascleral bleb was 1.8 mm3. In the
intrascleral bleb the aqueous resorp-
tion mechanism may be different
from that in the subconjunctival
space. The aqueous might be re-
sorbed by new aqueous drainage
vessels, as demonstrated by Delarive
and co-workers [4]. This study
showed that in the scleral space cre-
ated after deep sclerectomy, regard-
less of whether or not a collagen im-
plant was used, new aqueous humor
drainage vessels were growing and
resorbing the aqueous flowing
through the TDM.
By thinning the sclera by 90%,
aqueous humor outflow into the su-
prachoroidal space may occur; in
fact on UBM, it is possible to ob-
serve fluid between the ciliary body
and the remaining sclera in 45% of
the patients studied years after the
deep sclerectomy [13]. However,
this could also indicate chronic lo-
calized ciliary body detachment with
subsequent reduction of the aqueous
production [23]. Further studies on
aqueous dynamics following non-
penetrating filtering surgery are
needed to better understand the exact
mechanisms of aqueous drainage and
their respective importance in terms
of success and complications.
When performing the deep scler-
ectomy dissection, SC is opened and
unroofed. On either side of the deep
sclerectomy the two surgically creat-
ed ostia of SC may drain the aqueous
humor into the episcleral veins. This
mechanism is probably more impor-
tant after viscocanalostomy, during
which the ostia and SC are dilated.
Injection of viscoelastic material
into the two surgically created ostia
causes multiple ruptures in both in-
ner and outer endothelial walls of the
canal, as has been demonstrated [27]
in human and monkey eyes. These
ruptures extend into the JCT and
may also rupture some of the mesh-
work itself. In that respect, viscoca-
nalostomy seems to function as a
“delicate” trabeculotomy.
The future
Although we have taken some steps
in our understanding of how NPGS
functions, we are still hindered by
limited interest in NPGS basic re-
search, as well as lack of overall un-
derstanding of the pathological pro-
cess of glaucoma.
On the clinical side, NPGS has
been proved to be a safer technique
than other available surgical modali-
ties [1, 3, 6, 22, 26], including
trabeculectomy and drainage devic-
es. The question of efficacy, never-
theless, is far from resolved.
Controversial, often contradictory
[3, 6] results have been published.
As one browses between results,
though, one should keep in mind that
it is all about technique. Issues relat-
ed to which technique is superior to
which in the wide spectrum of NPGS
are of paramount importance. The
fact of an existing long learning
curve can not be overstated. It is nei-
ther meaningful nor scientifically
sound to compare one’s last 20 cases
of trabeculectomy to one’s first 20
deep sclerectomies [5, 11, 20].
With its apparent mechanisms of
function that seem to target specific
pathological structures in glaucoma,
NPGS deserves a fair chance.
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